Latest Breaking News On - Pharmaceutica ltd - Page 5 : comparemela.com

Basilea announces accelerated loan repayment

Basilea announces accelerated loan repayment
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtNils schrAdesh kaulHead of corporate communications investor relationsBasilea pharmaceutica ltdSwiss exchangePharmaceutica ltdAthyrium capital managementChief financial officerCorporate communications

Basilea Announces That FDA Approves Expanded Use Of Antifungal Cresemba® (Isavuconazole) In The United States In Children With Invasive Aspergillosis

Basilea Announces That FDA Approves Expanded Use Of Antifungal Cresemba® (Isavuconazole) In The United States In Children With Invasive Aspergillosis
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalBasel stadtMarc engelhardtStevens johnsonAstellas pharma us incEuropean medicines agencyEuropean commissionBasilea pharmaceutica ltdSwiss exchangeDrug administrationEuropean unionPharmaceutica ltdAstellas pharmaChief medical officerAdverse drug reactions

Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis

Basilea announces that FDA approves expanded use of antifungal Cresemba® (isavuconazole) in the United States in children with invasive aspergillosis and invasive mucormycosis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtUnited statesNils schrMarc engelhardtStevens johnsonJournal of the pediatric infectious diseases societyAstellas pharma us incEuropean commissionEuropean medicines agencyBasilea pharmaceutica ltdHead of corporate communications investor relationsSwiss exchangeDrug administrationEuropean unionPharmaceutica ltd

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers third sales milestone payment for the region from Pfizer this year
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalBasel stadtUnited statesAsia pacificDavid veitchIsavuconazole cresembaNils schrPfizer incBasilea pharmaceutica ltdHead of corporate communications investor relationsEuropean unionSwiss exchangePharmaceutica ltdChief executive officerCorporate communicationsPublic assessment report

Basilea announces acquisition of fosmanogepix, a phase-3-ready broad-spectrum antifungal

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting.

Basel stadtSwitzerland generalUnited statesDavid veitchCresemba zevteraNils schrDrug administrationAmplyx pharmaceuticals incSwiss exchangeHead of corporate communications investor relationsAmerican thoracic societyBasilea pharmaceutica international ltdBasilea pharmaceutica ltdPfizer incPharmaceutica ltdAmplyx pharmaceuticals